[{"Assets_0_Q2_USD":105370000.0,"CommonStockSharesOutstanding_0_Q2_shares":22705794.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-35019000.0,"NetIncomeLoss_1_Q2_USD":-18388000.0,"NetIncomeLoss_2_Q2_USD":-37785000.0,"StockholdersEquity_0_Q2_USD":70352000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":379000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":758000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]